AVASTIN INEFFECTIVE: The Food and Drug Administration said Thursday the best-selling cancer drug Avastin should no longer be used in breast cancer patients after failing to extend or improve patient lives in several studies.
CANCER CONTROVERSY: The FDA's decision was favored by many cancer experts but deplored by some cancer patients and physicians, who say Avastin has been a "miracle drug" for a select group of patients.
CHALLENGE: In an unusual move, drugmaker Roche is pushing back against FDA's ruling and has requested a public meeting to discuss Avastin's approval for breast cancer. If FDA accepts the company's requests, it would be the first meeting of its kind.
Clinton Foundation Received Donations from FIFA, Qatar 2022 World Cup Committee | Christine Rousselle
New Report Details Horrors of Iran Backed Terror Group Hamas: Torture, Beheadings, Acid, Mutilation | Katie Pavlich